Chinese drug maker investing $42M in Nabsys, report says

A REPORT from China Money Network said that a Chinese drug manufacturer is investing $42 million in Nabsys.
A REPORT from China Money Network said that a Chinese drug manufacturer is investing $42 million in Nabsys.
PROVIDENCE – A Chinese drug manufacturer is investing $42 million in Nabsys, which recently completed a financial restructuring that allowed it to reopen in March after being out of business for nearly seven months. The investment was reported Friday by China Money Network, a media company that follows news about the alternative investment industry in…

Want More?

Subscribe or register with Providence Business News to keep reading.

REGISTER
for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -